997 related articles for article (PubMed ID: 31536748)
1. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
2. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.
Li H; Hu B; Zhou ZQ; Guan J; Zhang ZY; Zhou GW
World J Surg Oncol; 2015 Apr; 13():161. PubMed ID: 25903488
[TBL] [Abstract][Full Text] [Related]
4. New epidemiologic trends in cholangiocarcinoma.
Pascale A; Rosmorduc O; Duclos-Vallée JC
Clin Res Hepatol Gastroenterol; 2023 Nov; 47(9):102223. PubMed ID: 37797807
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis.
Wongjarupong N; Assavapongpaiboon B; Susantitaphong P; Cheungpasitporn W; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
BMC Gastroenterol; 2017 Dec; 17(1):149. PubMed ID: 29216833
[TBL] [Abstract][Full Text] [Related]
6. Cholangiocarcinoma miscoding in hepatobiliary centres.
Selvadurai S; Mann K; Mithra S; Bridgewater J; Malik H; Khan SA
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):635-639. PubMed ID: 33032867
[TBL] [Abstract][Full Text] [Related]
7. Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
Javle M; Lee S; Azad NS; Borad MJ; Kate Kelley R; Sivaraman S; Teschemaker A; Chopra I; Janjan N; Parasuraman S; Bekaii-Saab TS
Oncologist; 2022 Oct; 27(10):874-883. PubMed ID: 35972334
[TBL] [Abstract][Full Text] [Related]
8. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.
Liao P; Cao L; Chen H; Pang SZ
Medicine (Baltimore); 2021 Apr; 100(16):e25635. PubMed ID: 33879742
[TBL] [Abstract][Full Text] [Related]
9. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland.
Barner-Rasmussen N; Pukkala E; Hadkhale K; Färkkilä M
United European Gastroenterol J; 2021 Dec; 9(10):1128-1135. PubMed ID: 34533900
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of cholangiocarcinoma.
Bergquist A; von Seth E
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
Plentz RR; Malek NP
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification.
Walter D; Ferstl P; Waidmann O; Trojan J; Hartmann S; Schnitzbauer AA; Zeuzem S; Kraywinkel K
Liver Int; 2019 Feb; 39(2):316-323. PubMed ID: 30176117
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocarcinoma: Epidemiology and risk factors.
Khan SA; Tavolari S; Brandi G
Liver Int; 2019 May; 39 Suppl 1():19-31. PubMed ID: 30851228
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation, diagnosis and staging of cholangiocarcinoma.
Forner A; Vidili G; Rengo M; Bujanda L; Ponz-Sarvisé M; Lamarca A
Liver Int; 2019 May; 39 Suppl 1():98-107. PubMed ID: 30831002
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy.
Donato F; Gelatti U; Tagger A; Favret M; Ribero ML; Callea F; Martelli C; Savio A; Trevisi P; Nardi G
Cancer Causes Control; 2001 Dec; 12(10):959-64. PubMed ID: 11808716
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: definitive evidence from meta-analysis and trial sequential analysis.
Corrao S; Natoli G; Argano C
Eur J Gastroenterol Hepatol; 2021 Jan; 33(1):62-68. PubMed ID: 32091438
[TBL] [Abstract][Full Text] [Related]
19. [Case-control study of risk factors in cholangiocarcinoma].
Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
[TBL] [Abstract][Full Text] [Related]
20. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia.
Shin HR; Oh JK; Masuyer E; Curado MP; Bouvard V; Fang Y; Wiangnon S; Sripa B; Hong ST
Asian Pac J Cancer Prev; 2010; 11(5):1159-66. PubMed ID: 21198257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
